Yuko Palesch to Follow-Up Studies
This is a "connection" page, showing publications Yuko Palesch has written about Follow-Up Studies.
Connection Strength
0.324
-
Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke. 2015 May; 46(5):1321-7.
Score: 0.081
-
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011 Dec; 15(3):559-76.
Score: 0.064
-
National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke. Stroke. 2020 01; 51(1):282-290.
Score: 0.028
-
Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage. Ann Neurol. 2019 01; 85(1):105-113.
Score: 0.026
-
Symptoms of depression in residents: a South Carolina Family Practice Research Consortium study. Acad Med. 1998 Dec; 73(12):1305-10.
Score: 0.026
-
Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury. J Neurotrauma. 2017 01 01; 34(1):115-120.
Score: 0.022
-
Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011 Nov; 42(11):3067-74.
Score: 0.016
-
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke. 2009 Nov; 40(11):3541-6.
Score: 0.014
-
The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat. 2009 Jul; 37(1):54-63.
Score: 0.013
-
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008 Oct; 7(10):875-84.
Score: 0.013
-
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008 Sep 18; 359(12):1225-37.
Score: 0.013
-
Long-term follow-up of absence seizures. Neurology. 1983 Dec; 33(12):1590-5.
Score: 0.009